<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Reversal of CENVAT Credit Overturned Due to Lack of Evidence on Manufacturing Exempt Hemophilus Vaccine.</title>
    <link>https://www.taxtmi.com/highlights?id=72849</link>
    <description>Reversal of CENVAT Credit - manufacture and clearance of Hemophilus Vaccine which is duty free - The Department having not negated the claims of the appellant that it was not the appellants who have manufactured impugned exempted product i.e the Hemophilus Flu Vaccine. Therefore, there are no case made by the Department to invoke the provisions of Rule 6(3) of the CCR, 2004. - AT</description>
    <language>en-us</language>
    <pubDate>Thu, 02 Nov 2023 08:29:08 +0530</pubDate>
    <lastBuildDate>Thu, 02 Nov 2023 08:29:08 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=731006" rel="self" type="application/rss+xml"/>
    <item>
      <title>Reversal of CENVAT Credit Overturned Due to Lack of Evidence on Manufacturing Exempt Hemophilus Vaccine.</title>
      <link>https://www.taxtmi.com/highlights?id=72849</link>
      <description>Reversal of CENVAT Credit - manufacture and clearance of Hemophilus Vaccine which is duty free - The Department having not negated the claims of the appellant that it was not the appellants who have manufactured impugned exempted product i.e the Hemophilus Flu Vaccine. Therefore, there are no case made by the Department to invoke the provisions of Rule 6(3) of the CCR, 2004. - AT</description>
      <category>Highlights</category>
      <law>Central Excise</law>
      <pubDate>Thu, 02 Nov 2023 08:29:08 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/highlights?id=72849</guid>
    </item>
  </channel>
</rss>